new video loaded: F.D.A. Panel Greenlights Moderna Boosters for High-Risk Individuals
F.D.A. Panel Greenlights Moderna Boosters for High-Risk Individuals
A Food and Drug Administration advisory panel recommended a half-dose as a third injection for people 65 and older as well as younger adults at high risk because of their medical conditions or jobs.
“Do available data support the safety and effectiveness of Moderna Covid-19 vaccine for use under EUA as a booster dose, 50 micrograms mRNA-1273, at least six months after completion of a primary series in the following populations: individuals 65 years of age and older, individuals 18 to 64 years of age at high-risk of severe Covid-19 and individuals 18 through 64 years of age, whose frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of Covid-19, including severe Covid-19?” “We do have a unanimous 19 out of 19 yes votes, and that concludes the voting portion.”
Recent episodes in Coronavirus Pandemic: Latest Updates